Great West Life Assurance CO Rocket Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 6,276 shares of RCKT stock, worth $112,026. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,276
Previous 6,276
-0.0%
Holding current value
$112,026
Previous $169,000
20.12%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RCKT
# of Institutions
194Shares Held
91.9MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$316 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$163 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$111 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$104 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$77.3 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.35B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...